Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000172

EVP, Chf Clinical Develop Ofcr sold 9,549 shares at $42.80 ($408,701)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Schneider Eugene EVP, Chf Clinical Develop Ofcr 2025-08-04 Sale 10b5-1 −9,549 $42.80 $408,701 51,507 D: show line 1 in the form
Open-market sales · 9,549 sh · avg $42.80 · $408,701
Loading xslF345X05/edgardoc.xml…